Greenwich LifeSciences, Inc. STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on ...
Greenwich LifeSciences, Inc. STAFFORD, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on ...
Several hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN grew its position in shares of Greenwich LifeSciences by 54.8% in the fourth quarter. Wells Fargo ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100 ...
After hours: 7 February at 4:20:00 pm GMT-5 ...
After hours: 14 February at 4:01:57 pm GMT-5 ...
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
The BNY Mellon Global Stock Fund underperformed the MSCI World Index for the fourth quarter of 2024. Read more here.
Mega Lifesciences President International Paramjit Singh Sawnhey was in Sri Lanka recently and met some of the company’s close associates. Singh covers half the globe with more than 90 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results